Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Clark

Showing results (1481-1490 of 1,669) with videos related to

Pageof 167
Sort By:
Frontiers in Molecular Biosciences|February 29, 2024
2'-<sup>19</sup>F labelling of ribose in RNAs: a tool to analyse RNA/protein interactions by NMR in physiological conditionsHesna Kara, Alexander Axer, Frederick W Muskett, et al.
The Oncologist|May 21, 2010
Plasma soluble VEGFR-1 is a potential dual biomarker of response and toxicity for bevacizumab with chemoradiation in locally advanced rectal cancerDan G Duda, Christopher G Willett, Marek Ancukiewicz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2009
Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancerP C Enzinger, D P Ryan, J W Clark, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 4, 2015
Protective effects of surfactant protein D treatment in 1,3-β-glucan-modulated allergic inflammationDalia Fakih, Bartosz Pilecki, Anders Schlosser, et al.
Journal of Environmental Management|July 5, 2021
Challenges and opportunities for sustaining coastal wetlands and oyster reefs in the southeastern United StatesTricia Kyzar, Ilgar Safak, Just Cebrian, et al.
The Oncologist|January 3, 2012
Panitumumab in patients with KRAS wild-type colorectal cancer after progression on cetuximabRaymond C Wadlow, Aram F Hezel, Thomas A Abrams, et al.
Journal of the American Chemical Society|February 2, 2013
Surface-induced orientation control of CuPc molecules for the epitaxial growth of highly ordered organic crystals on grapheneKai Xiao, Wan Deng, Jong K Keum, et al.
The New England Journal of Medicine|May 13, 2026
Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household ContactsFrederick G Hayden, Masaharu Shinkai, Tristan W Clark, et al.
Respiratory Research|September 23, 2020
Inflammatory phenotyping predicts clinical outcome in COVID-19H Burke, A Freeman, D C Cellura, et al.
Cancer Research|October 15, 2009
Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancerLei Xu, Dan G Duda, Emmanuelle di Tomaso, et al.
Pageof 167

Showing results (1481-1490 of 1,669) with videos related to

Sort By:
Pageof 167
Frontiers in Molecular Biosciences|February 29, 2024
2'-<sup>19</sup>F labelling of ribose in RNAs: a tool to analyse RNA/protein interactions by NMR in physiological conditionsHesna Kara, Alexander Axer, Frederick W Muskett, et al.
The Oncologist|May 21, 2010
Plasma soluble VEGFR-1 is a potential dual biomarker of response and toxicity for bevacizumab with chemoradiation in locally advanced rectal cancerDan G Duda, Christopher G Willett, Marek Ancukiewicz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2009
Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancerP C Enzinger, D P Ryan, J W Clark, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 4, 2015
Protective effects of surfactant protein D treatment in 1,3-β-glucan-modulated allergic inflammationDalia Fakih, Bartosz Pilecki, Anders Schlosser, et al.
Journal of Environmental Management|July 5, 2021
Challenges and opportunities for sustaining coastal wetlands and oyster reefs in the southeastern United StatesTricia Kyzar, Ilgar Safak, Just Cebrian, et al.
The Oncologist|January 3, 2012
Panitumumab in patients with KRAS wild-type colorectal cancer after progression on cetuximabRaymond C Wadlow, Aram F Hezel, Thomas A Abrams, et al.
Journal of the American Chemical Society|February 2, 2013
Surface-induced orientation control of CuPc molecules for the epitaxial growth of highly ordered organic crystals on grapheneKai Xiao, Wan Deng, Jong K Keum, et al.
The New England Journal of Medicine|May 13, 2026
Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household ContactsFrederick G Hayden, Masaharu Shinkai, Tristan W Clark, et al.
Respiratory Research|September 23, 2020
Inflammatory phenotyping predicts clinical outcome in COVID-19H Burke, A Freeman, D C Cellura, et al.
Cancer Research|October 15, 2009
Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancerLei Xu, Dan G Duda, Emmanuelle di Tomaso, et al.
Pageof 167